Department of Molecular Neuroscience, Graduate School of Medicine, Osaka University, Suita-shi, Osaka, Japan.
Neurosci Res. 2011 Nov;71(3):266-77. doi: 10.1016/j.neures.2011.07.1830. Epub 2011 Jul 28.
c-Jun N-terminal kinase (JNK) mediates neuronal death in response to stress and injury in the CNS and peripheral nervous system. Here, we show that JNK also regulates retrograde axonal degeneration (axonal dieback) after spinal cord injury (SCI) in mice. Activated phospho-JNK was highly expressed in damaged corticospinal tract (CST) axons after thoracic SCI by hemisection. Local administration of SP600125, a JNK inhibitor, prevented accumulation of amyloid-β precursor protein and retraction of the severed CST axons as well as preserved the axonal arbors rostral to the injury site. The treatment with SP600125 also improved functional recovery of the hindlimbs, assessed by Basso mouse scale open-field scores and the grid-walking test. In Jnk1(-/-) and Jnk3(-/-) mice, we observed prevention of axonal degeneration and enhancement of motor recovery after SCI. These results indicate that both JNK1 and JNK3 induce axonal degeneration and limit motor recovery after SCI. Thus, a JNK inhibitor may be a suitable therapeutic agent for SCI.
c-Jun N-末端激酶(JNK)介导中枢神经系统和周围神经系统对应激和损伤的神经元死亡。在这里,我们表明 JNK 也调节脊髓损伤(SCI)后小鼠的逆行轴突变性(轴突退变)。通过半切,胸椎 SCI 后,磷酸化 JNK 在受损皮质脊髓束(CST)轴突中高度表达。局部给予 SP600125,一种 JNK 抑制剂,可防止淀粉样前体蛋白的积累和 CST 轴突的回缩,并保留损伤部位近端的轴突树突。SP600125 的治疗还改善了后肢的功能恢复,通过 Basso 小鼠量表旷场评分和网格行走测试进行评估。在 Jnk1(-/-)和 Jnk3(-/-)小鼠中,我们观察到 SCI 后轴突变性的预防和运动恢复的增强。这些结果表明,JNK1 和 JNK3 均诱导 SCI 后轴突变性并限制运动恢复。因此,JNK 抑制剂可能是 SCI 的一种合适的治疗剂。